135 related articles for article (PubMed ID: 37772542)
1. Inherent efficacies of pyrazole-based derivatives for cancer therapy: the interface between experiment and
Dube ZF; Soremekun OS; Ntombela T; Alahmdi MI; Abo-Dya NE; Sidhom PA; Shawky AM; Shibl MF; Ibrahim MA; Soliman ME
Future Med Chem; 2023 Sep; 15(18):1719-1738. PubMed ID: 37772542
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation and molecular docking of novel pyrazole derivatives as potent carbonic anhydrase and acetylcholinesterase inhibitors.
Turkan F; Cetin A; Taslimi P; Karaman M; Gulçin İ
Bioorg Chem; 2019 May; 86():420-427. PubMed ID: 30769267
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological evaluation and molecular docking of benzimidazole grafted benzsulfamide-containing pyrazole ring derivatives as novel tubulin polymerization inhibitors.
Wang YT; Shi TQ; Zhu HL; Liu CH
Bioorg Med Chem; 2019 Feb; 27(3):502-515. PubMed ID: 30606674
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.
Lai Q; Wang Y; Wang R; Lai W; Tang L; Tao Y; Liu Y; Zhang R; Huang L; Xiang H; Zeng S; Gou L; Chen H; Yao Y; Yang J
Eur J Med Chem; 2018 Aug; 156():162-179. PubMed ID: 30006162
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Substituted Pyrazole-Based Kinase Inhibitors in One Decade (2011-2020): Current Status and Future Prospects.
El-Gamal MI; Zaraei SO; Madkour MM; Anbar HS
Molecules; 2022 Jan; 27(1):. PubMed ID: 35011562
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, molecular modeling, and biological evaluation of pyrazole-naphthalene derivatives as potential anticancer agents on MCF-7 breast cancer cells by inhibiting tubulin polymerization.
Wang G; Liu W; Peng Z; Huang Y; Gong Z; Li Y
Bioorg Chem; 2020 Oct; 103():104141. PubMed ID: 32750611
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of pyrazole/isoxazole linked arylcinnamides as tubulin polymerization inhibitors and potential antiproliferative agents.
Kamal A; Shaik AB; Rao BB; Khan I; Bharath Kumar G; Jain N
Org Biomol Chem; 2015 Oct; 13(40):10162-78. PubMed ID: 26303171
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, in silico and antiproliferative evaluation of novel pyrazole derivatives as VEGFR-2 inhibitors.
Ravula P; Vamaraju HB; Paturi M; Sharath Chandra JNGN
Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29205467
[TBL] [Abstract][Full Text] [Related]
9. Discovery, synthesis and molecular corroborations of medicinally important novel pyrazoles; drug efficacy determinations through in silico, in vitro and cytotoxicity validations.
Thangarasu P; Manikandan A; Thamaraiselvi S
Bioorg Chem; 2019 May; 86():410-419. PubMed ID: 30769266
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Outlook of Pyrazole Analogs: A Mini Review.
Ganguly S; Jacob SK
Mini Rev Med Chem; 2017; 17(11):959-983. PubMed ID: 26586126
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and molecular modelling studies of some pyrazole derivatives as carbonic anhydrase inhibitors.
Dizdaroglu Y; Albay C; Arslan T; Ece A; Turkoglu EA; Efe A; Senturk M; Supuran CT; Ekinci D
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):289-297. PubMed ID: 31797703
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of novel 5-phenyl-1H-pyrazole derivatives as potential BRAF(V600E) inhibitors.
Wang SF; Zhu YL; Zhu PT; Makawana JA; Zhang YL; Zhao MY; Lv PC; Zhu HL
Bioorg Med Chem; 2014 Nov; 22(21):6201-8. PubMed ID: 25267006
[TBL] [Abstract][Full Text] [Related]
13. Polymer microspheres modified with pyrazole derivatives as potential agents in anticancer therapy - Preliminary studies.
Podkościelna B; Klimek K; Karczmarzyk Z; Wysocki W; Brodacka M; Serafin K; Kozyra P; Kowalczuk D; Ginalska G; Pitucha M
Bioorg Chem; 2022 Jun; 123():105765. PubMed ID: 35427940
[TBL] [Abstract][Full Text] [Related]
14. Insights into the Pharmacological Activity of the Imidazo-Pyrazole Scaffold.
Spallarossa A; Rapetti F; Signorello MG; Rosano C; Iervasi E; Ponassi M; Brullo C
ChemMedChem; 2023 Sep; 18(17):e202300252. PubMed ID: 37366115
[TBL] [Abstract][Full Text] [Related]
15. Chloro and bromo-pyrazole curcumin Knoevenagel condensates augmented anticancer activity against human cervical cancer cells: design, synthesis,
Chaudhary M; Kumar N; Baldi A; Chandra R; Arockia Babu M; Madan J
J Biomol Struct Dyn; 2020 Jan; 38(1):200-218. PubMed ID: 30784365
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel vicinal diaryl-substituted 1H-Pyrazole analogues of combretastatin A-4 as highly potent tubulin polymerization inhibitors.
Romagnoli R; Oliva P; Salvador MK; Camacho ME; Padroni C; Brancale A; Ferla S; Hamel E; Ronca R; Grillo E; Bortolozzi R; Rruga F; Mariotto E; Viola G
Eur J Med Chem; 2019 Nov; 181():111577. PubMed ID: 31400707
[TBL] [Abstract][Full Text] [Related]
17. Appraisal of the Role of In silico Methods in Pyrazole Based Drug Design.
Sharma S; Bhatia V
Mini Rev Med Chem; 2021; 21(2):204-216. PubMed ID: 32875985
[TBL] [Abstract][Full Text] [Related]
18. Discovery of N-(benzyloxy)-1,3-diphenyl-1H-pyrazole-4-carboxamide derivatives as potential antiproliferative agents by inhibiting MEK.
Lv XH; Ren ZL; Zhou BG; Li QS; Chu MJ; Liu DH; Mo K; Zhang LS; Yao XK; Cao HQ
Bioorg Med Chem; 2016 Oct; 24(19):4652-4659. PubMed ID: 27515719
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and molecular docking of novel pyrazole-chalcone analogs of lonazolac as 5-LOX, iNOS and tubulin polymerization inhibitors with potential anticancer and anti-inflammatory activities.
Ahmed AHH; Mohamed MFA; Allam RM; Nafady A; Mohamed SK; Gouda AE; Beshr EAM
Bioorg Chem; 2022 Dec; 129():106171. PubMed ID: 36166898
[TBL] [Abstract][Full Text] [Related]
20. Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation.
Said MA; Eldehna WM; Nocentini A; Fahim SH; Bonardi A; Elgazar AA; Kryštof V; Soliman DH; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT
Eur J Med Chem; 2020 Mar; 189():112019. PubMed ID: 31972394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
